ZA9710130B - Attenuated live neospora vaccine - Google Patents

Attenuated live neospora vaccine

Info

Publication number
ZA9710130B
ZA9710130B ZA9710130A ZA9710130A ZA9710130B ZA 9710130 B ZA9710130 B ZA 9710130B ZA 9710130 A ZA9710130 A ZA 9710130A ZA 9710130 A ZA9710130 A ZA 9710130A ZA 9710130 B ZA9710130 B ZA 9710130B
Authority
ZA
South Africa
Prior art keywords
attenuated live
live neospora
neospora vaccine
vaccine
attenuated
Prior art date
Application number
ZA9710130A
Other languages
English (en)
Inventor
David A Brake
Byron L Blagburn
David S Lindsay
Original Assignee
Pfizer
Univ Auburn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21858396&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA9710130(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer, Univ Auburn filed Critical Pfizer
Publication of ZA9710130B publication Critical patent/ZA9710130B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9710130A 1996-11-12 1997-11-11 Attenuated live neospora vaccine ZA9710130B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3124896P 1996-11-12 1996-11-12

Publications (1)

Publication Number Publication Date
ZA9710130B true ZA9710130B (en) 1999-06-10

Family

ID=21858396

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9710130A ZA9710130B (en) 1996-11-12 1997-11-11 Attenuated live neospora vaccine

Country Status (16)

Country Link
US (3) US6656479B2 (da)
EP (1) EP0841392B1 (da)
JP (2) JP3690709B2 (da)
CN (2) CN1572322A (da)
AR (2) AR010583A1 (da)
AT (1) ATE271122T1 (da)
AU (1) AU733076B2 (da)
BR (1) BR9705473A (da)
CA (1) CA2220588C (da)
DE (1) DE69729839T2 (da)
DK (1) DK0841392T3 (da)
ES (1) ES2224210T3 (da)
NZ (1) NZ329095A (da)
PT (1) PT841392E (da)
TW (1) TW557214B (da)
ZA (1) ZA9710130B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT841392E (pt) * 1996-11-12 2004-11-30 Univ Auburn Vacina viva atenuada de neospora
BR9803232A (pt) * 1997-08-26 2000-01-11 Pfizer Prod Inc Vaicna de neospora.
JP2001520205A (ja) * 1997-10-20 2001-10-30 バイエル・コーポレーシヨン ネオスポラワクチン
EP0953641A3 (en) * 1998-03-26 2002-03-13 Pfizer Products Inc. Polynucleotide molecules encoding neospora proteins
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
AUPQ905600A0 (en) * 2000-07-28 2000-08-24 Insearch Limited Parasites
WO2003038434A2 (en) * 2001-10-31 2003-05-08 Pfizer Products Inc. Serological assay for neospora caninum
FR2836924B1 (fr) * 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
PT1646715E (pt) 2003-07-22 2010-08-09 Vivalis Produção de poxvírus com linhagem das células aviarias aderentes ou não aderentes
BRPI0417762A8 (pt) * 2003-12-19 2015-12-22 Seattle Biomedical Res Institute Organismo vivo, um plasmodium, método para inocular um hospedeiro vertebrado contra malária, composição de vacina, uso de um organismo vivo, um plasmodium, e, método de produção de uma composição de vacina
US7722860B2 (en) * 2004-12-03 2010-05-25 Seattle Biomedical Research Institute Live genetically engineered protozoan vaccine
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
ES2319242B1 (es) 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
CN101506354B (zh) 2006-08-09 2014-05-07 瓦内瓦公司 用胚胎干细胞制备转基因禽类的方法
EP1985305A1 (en) 2007-04-24 2008-10-29 Vivalis Duck embryonic derived stem cell lines for the production of viral vaccines
EP1995309A1 (en) * 2007-05-21 2008-11-26 Vivalis Recombinant protein production in avian EBx® cells
ES2326770B1 (es) 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
FR2994193B1 (fr) * 2012-08-02 2016-05-20 Vitamfero Souches mutantes de neospora et leurs utilisations
NZ742210A (en) 2015-10-28 2023-06-30 Univ Madrid Complutense Neospora vaccine composition
CA3037544C (en) 2016-10-05 2021-10-12 Zoetis Services Llc Lyophilization methods that provide stably dehydrated protozoans for use as potent live vaccines
EP3802841A1 (en) 2018-05-30 2021-04-14 Institute for Research in Biomedicine Engineering b lymphocytes by utilizing endogenous activation-induced cytidine deaminase
CN111187721A (zh) * 2020-01-17 2020-05-22 中国农业大学 grx 5基因缺失的新孢子虫弱毒虫株及其构建方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976553A (en) 1993-11-04 1999-11-02 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5643718A (en) * 1993-11-04 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US6716423B1 (en) * 1994-03-21 2004-04-06 The Regents Of The University Of California Recombinant neospora antigens and their uses
US5707617A (en) 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
US5889166A (en) * 1996-05-10 1999-03-30 The Regents Of The University Of California Recombinant neospora antigens and their uses
US6743430B1 (en) * 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
WO1997017082A1 (en) * 1995-11-09 1997-05-15 Trustees Of Dartmouth College A vaccine against toxoplasma gondii
PT841392E (pt) * 1996-11-12 2004-11-30 Univ Auburn Vacina viva atenuada de neospora
US6071737A (en) 1998-03-16 2000-06-06 The Regents Of The University Of California Equine Neospora isolate and its uses

Also Published As

Publication number Publication date
JP2005230018A (ja) 2005-09-02
US20020044952A1 (en) 2002-04-18
CA2220588C (en) 2008-07-22
CN1190127A (zh) 1998-08-12
DE69729839T2 (de) 2005-07-21
JPH10167983A (ja) 1998-06-23
JP3935180B2 (ja) 2007-06-20
CN1572322A (zh) 2005-02-02
NZ329095A (en) 1998-03-25
BR9705473A (pt) 1999-04-06
DK0841392T3 (da) 2004-11-22
PT841392E (pt) 2004-11-30
ATE271122T1 (de) 2004-07-15
US6656479B2 (en) 2003-12-02
MX9708701A (es) 1998-09-30
EP0841392A3 (en) 1999-03-24
AR053286A2 (es) 2007-04-25
CA2220588A1 (en) 1998-05-12
AR010583A1 (es) 2000-06-28
ES2224210T3 (es) 2005-03-01
US6994861B2 (en) 2006-02-07
US20040062772A1 (en) 2004-04-01
US20060073157A1 (en) 2006-04-06
TW557214B (en) 2003-10-11
JP3690709B2 (ja) 2005-08-31
AU4520397A (en) 1998-05-14
DE69729839D1 (de) 2004-08-19
CN1226406C (zh) 2005-11-09
EP0841392A2 (en) 1998-05-13
EP0841392B1 (en) 2004-07-14
AU733076B2 (en) 2001-05-03

Similar Documents

Publication Publication Date Title
GB9711964D0 (en) Live attenuated vaccines
IL128985A0 (en) Vaccines
AU4520397A (en) Attenuated live neospora vaccine
EP0958373A4 (en) Vaccines.
GB9616351D0 (en) Vaccine composition
GB9623233D0 (en) Vaccine composition
ZA9711565B (en) Vaccine
GB2312740B (en) Ventilation device
GB9625968D0 (en) Vaccine
GB2312047B (en) Improved pipework
GB2316998B (en) Condensate traps
GB9417880D0 (en) Vaccine
GB9616593D0 (en) Attenuated vaccines
ZA973824B (en) Vaccines
GB9616786D0 (en) Catch
GB9625967D0 (en) Vaccine
GB9625966D0 (en) Vaccine
GB9419969D0 (en) Vaccine
GB9627145D0 (en) Teat
GB9606032D0 (en) Vaccines
GB9614182D0 (en) Vaccines
GB9602617D0 (en) Vaccines
GB9604596D0 (en) Vaccines
GB9626882D0 (en) Vaccines
GB9605229D0 (en) Vaccines